| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0009 | 1 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.0061 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.003 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00048 | 1 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.00088 | 1 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.00083 | 1 |